American Journal of Obstetrics & Gynecology
Volume 198, Issue 3 , Pages 260.e1-260.e2 , March 2008

Rectovaginal examinations and human papillomavirus: can we decrease the risk of colorectal infection?

  • William W. Hurd, MD

      Affiliations

    • Corresponding Author InformationReprints: William W. Hurd, MD, 128 East Apple St, CHE 3800, Dayton, OH 45409

References 

  1. Bray F, Loos AH, McCarron P, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev. 2005;14:677–686
  2. Davisson L, Clark K, Powers R, Hobbs G. The rectovaginal examination: physician attitudes and practice patterns. South Med J. 2006;99:212–215
  3. Ault KA. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol. 2006;14:1–5
  4. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997;102:3–8
  5. Centers for Disease Control and Prevention. Genital HPV infection—CDC fact sheet. Atlanta: Centers for Disease Control and Prevention; 2004;
  6. Ferlay J, Bray F, Pisani P. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide (IARC cancer base no. 5, version 2.0). Lyon: IARCPress; 2004;
  7. Kaufman RH, Adam E, Icenogle J, Reeves WC. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness. Am J Obstet Gynecol. 1997;177:930–936
  8. Bettinger D, Bernard B, Riethmuller D, et al. Detection of human papillomaviruses in paraffin-embedded biopsies of cervical intraepithelial lesions: analysis by immunohistochemistry, in situ hybridization, and the polymerase chain reaction. Mod Pathol. 1994;7:113–119
  9. Perez LO, Abba MC, Laguens RM, Golijow CD. Analysis of adenocarcinoma of the colon and rectum: detection of human papillomavirus (HPV) DNA by polymerase chain reaction. Colorectal Dis. 2005;7:492–495
  10. Weinberger PM, Zerkowski M, Chung G, Camp RL, Rimm DL, Psyrri D. A possible association of human papilloma virus with a subset of colorectal adenocarcinomas. J Clin Oncol. 2004;22(Suppl):14S
  11. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8–29
  12. Gibbons L, Waters C, Mao Y, et al. Trends in colorectal cancer incidence and mortality. Health Reports. 2001;12:1–15
  13. Roden RB, Lowy DR, Schiller JT. Papillomavirus is resistant to desiccation. J Infect Dis. 1997;176:1076–1079
  14. Oriel JD. Natural history of genital warts. Br J Vener Dis. 1971;47:1–13
  15. Sinclair KA, Woods CR, Kirse DJ, Sinal SH. Anogenital and respiratory tract human papillomavirus infections among children: age, gender, and potential transmission through sexual abuse. Pediatrics. 2005;116:815–825
  16. Frega A, Cenci M, Stentella P, et al. Human papillomavirus in virgins and behaviour at risk. Cancer Lett. 2003;194:21–24
  17. Moscicki AB, Hills NK, Shiboski S, et al. Risk factors for abnormal anal cytology in young heterosexual women. Cancer Epidemiol Biomarkers Prev. 1999;8:173–178
  18. Belinson J, Qiao Y, Pretorius R, et al. Prevalence of cervical cancer and feasibility of screening in rural China: a pilot study for the Shanxi Province Cervical Cancer Screening Study. Int J Gynecol Cancer. 1999;9:411–417
  19. American College of Obstetricians and Gynecologists. Guidelines for women’s health care. 2nd ed.. Washington, DC: ACOG; 2002;

 Cite this article as: Hurd WW. Rectovaginal examinations and human papillomavirus: can we decrease the risk of colorectal infection? Am J Obstet Gynecol 2008;198:260.e1-260.e2.

PII: S0002-9378(07)00554-6

doi: 10.1016/j.ajog.2007.04.034

American Journal of Obstetrics & Gynecology
Volume 198, Issue 3 , Pages 260.e1-260.e2 , March 2008

Article Tools